Amag Pharmaceuticals Inc., of Waltham, Mass., reported that it has submitted a supplemental new drug application to the FDA for Makena (Hydroxyprogesterone Caproate Injection) subcutaneous auto-injector, its drug-device product. Amag developed the new product with Antares Pharma Inc., of Ewing, N.J.